Thus, the polyreactivity of the BCR on UM-CLL cells allows binding to a variety of self and foreign antigens [14], and constitutive signals generated by this engagement are thought to contribute to disease progression. The gene discussed is BCR; the disease is B-cell chronic lymphocytic leukemia.